Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.6B | 2.6B | 2.7B | 2.8B |
Cost of revenue | 1.6B | 1.6B | 1.6B | 1.6B |
Gross profit | 1.0B | 1.0B | 1.1B | 1.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 855M | 898M | 819M | 872M |
Other operating expenses | 1M | 1M | 5M | -1M |
Operating income | 192M | 127M | 259M | 270M |
Non operating interest income | ||||
Income | — | — | 12M | 16M |
Expense | 30M | 36M | 45M | 47M |
Other income expense | — | — | — | — |
Pretax income | 169M | 95M | 247M | 244M |
Tax provision | 48M | 59M | 77M | 53M |
Net income | 121M | 36M | 170M | 192M |
Basic EPS | 0.6 | 0.1 | 1.0 | 1.0 |
Diluted EPS | 0.6 | 0.1 | 1.0 | 1.0 |
Basic average shares | 170.8M | 170.8M | 170.8M | 170.7M |
Diluted average shares | 172.6M | 170.8M | 170.8M | 170.8M |
EBITDA | 293M | 225M | 388M | 383M |
Net income from continuing op. | 121M | 36M | 170M | 191M |
Minority interests | -14M | -15M | -7M | -15M |
Preferred stock dividends | 0 | 0 | 0 | 0 |